Unchained Labs Unveils Innovative Solutions for Nanoparticle Development
Unchained Labs, a prominent player in life sciences, has taken a significant leap forward in the realm of therapeutic nanoparticle research with the introduction of two groundbreaking tools: Stunner AF and a collection of Sunshine systems. Aimed at providing essential support to biologics and gene therapy researchers, these innovations promise to refine and streamline the nanoparticle development process, making it both faster and more efficient.
What is Stunner AF?
At the forefront of this evolution is Stunner AF, an advanced platform designed explicitly for lipid nanoparticle (LNP) characterization. Its unique capability to combine essential measurements, such as encapsulation efficiency, sizing, polydispersity, particle concentration, and aggregation detection, makes it a game changer in the field. By utilizing a 96-well Stunner plate, researchers can easily load their standards and prepped LNPs. Through the trifecta of ultraviolet/visible (UV/Vis) light, rotating angle dynamic light scattering (RADLS), and fluorescence, the Stunner AF delivers unparalleled insight into LNP characteristics — fast, accurate, and comprehensive. In essence, it acts as a definitive reality check on the quality and efficacy of nanoparticles, which is crucial in therapeutic applications.
The Sunshine Series: Supporting All Stages of Nanoparticle Development
Complementing Stunner AF, Unchained Labs has rolled out the Sunshine systems — a versatile family of tools designed for every step of nanoparticle development. Whether researchers are fine-tuning their payloads, adjusting flow rates, or experimenting with various mixing methodologies, there's a Sunshine system tailored to their needs. The series includes:
- - Sunshine Single: Ideal for quick, individual automated runs.
- - Sunshine Lite: Designed for automated runs of multiple experiments, providing flexibility in experimental design.
- - Full Sunshine: The comprehensive option features continuous flow capabilities, allowing the synthesis of liters of nanoparticles combined with in-line dilution.
All Sunshine systems utilize the same reusable Sunny microfluidic mixing devices, enhancing user experience and operational efficiency.
Enhancing Research with Clarity
Taegen Clary, Chief Commercial Officer at Unchained Labs, emphasized the critical advantage offered by Stunner AF and the Sunshine series: "Researchers shouldn't have to juggle multiple analytical tools to get one clear picture of their LNPs," she stated. With Stunner AF providing a holistic view of LNP quantity, quality, and payload status, scientists can focus on innovation rather than tool management. The Sunshine systems further support their journey by enabling easy transitions between various experimental settings, accommodating both initial experimentation and scaling up for larger production needs.
A Commitment to Innovation
Unchained Labs stands firm in its mission to empower biologics and gene therapy researchers. By providing innovative solutions that address the common challenges faced in nanoparticle development, they are not just enhancing laboratory efficiency; they're also enabling groundbreaking advancements in therapeutics. With their base located in Pleasanton, CA, Unchained Labs continues to lead the charge in transforming research through user-friendly, effective technologies.
For more information on Stunner AF and the Sunshine systems, visit
Unchained Labs.
In conclusion, the advancements brought forth by Unchained Labs are set to redefine the landscape of nanoparticle research, paving the way for more effective therapeutic solutions in the future. Leaders in the field can look forward to utilizing these remarkable tools that promise to elevate their research capabilities, keeping them at the forefront of scientific discovery.